AN UNBIASED VIEW OF ACTAVIS XANAX

Spontaneous reporting process data suggest that the risk of dependence and its severity appear to be higher in clients addressed with doses better than 4 mg/day and for very long intervals (a lot more than 12 months). However, in a very controlled postmarketing discontinuation study of stress disorder patients who received XANAX, the duration of cu